Events Search and Views Navigation
The course "Mathematical Models for Advocates and Journalists" will begin on Monday, May 25th. Prior to the start of the course, please join a Kick-Off…Find out more »
Learners will work closely with facilitators over 10 weeks to develop a program that is unique to their individual context and needs. We have several outside expert speakers coming in discussing integrating gender strategy, monitoring and evaluation planning and communication (media and trial results)Find out more »
The COVID-19 pandemic has accelerated the research process. Sponsors, researchers, ethics committee members and other stakeholders are moving faster than ever to move effective products…Find out more »
Dr. N'Dung'u is providing the plenary talk on HIV vaccine and cure research at AIDS 2020. In this conversation, Dr. N'Dung'u responds to questions about…Find out more »
Devin Sok, Direction of Antibody Discovery and Development, and Olayinka Fagbayi, Program Director Neutralizing Antibody Center, of IAVI will discuss the antibody pipeline. They will…Find out more »
Join Sinead Delany-Moreltwe, the PI of HPTN 084 in a conversation about the ongoing clinical trial of long-acting PrEP. Dr. Delany-Moreltwe will discuss a range…Find out more »
During the COVID-19 outbreak the Tangerine clinic, the first transgender-led clinic in Thailand, has adapted many of the health services offered to an online model. This pivot has included providing online tutorials and support for personal sample collection and medication delivery. Our speaker, Rena Janamnuaysook, will discuss these adaptations as well as strategies to build and support stakeholder engagement programs with key populations.
Check out the Community of Practice Group for more resources!Find out more »
Globally, research teams are embarking on various clinical trials focused on finding a COVID-19 vaccine. However, efforts to
find a vaccine are characterized by misinformation, anti-vaccine sentiments, conspiracy theories, general distrust, or safety
Growing evidence shows that these challenges lead to serious public health consequences, including vaccine hesitancy, increased
public fear and low in vaccine confidence. These challenges may lead to lower vaccine acceptability when the COVID-19 vaccine
becomes available. During this webinar, experts will unpack the determinants of vaccine hesitancy and how it can serve as
a barrier to uptake of the COVID-19 vaccine. They will also share strategies that can be used by advocates and community
engagement practitioners in response to misinformation, rumours, in order to build and sustain vaccine confidence.